Home

Steven Kelly

CIK 1339478 · President and CEO · last filed 2026-07-21

Steven Kelly is a President and CEO who has filed 17 SEC Form 4 insider transactions across 3 companies since 2019. The most recent filing, for ARTL, was dated Jul 21, 2026.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

3

Total Filings

17

Lifetime Open-Market Net

$0

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ARTL Director — $0.75 — $0 3 2026-07-21
Carisma Therapeutics Inc. (CARM) Delisted President and CEO — $0.00 — $0 4 2025-01-30
ARTELO BIOSCIENCES, INC. (ARTLW) Delisted Director — $0.01 — $0 7 2024-03-01

Recent Filings

17 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-07-21 ARTL Grant (A) — $0 EDGAR
2026-02-02 ARTL Grant (A) — $0 EDGAR
2025-01-30 Carisma Therapeutics Inc. (CARM) Delisted Grant (A) — $0 EDGAR
2024-12-23 ARTL Grant (A) — $0 EDGAR
2024-06-18 Carisma Therapeutics Inc. (CARM) Delisted Grant (A) — $0 EDGAR
2024-03-01 ARTELO BIOSCIENCES, INC. (ARTLW) Delisted Mixed — $0 EDGAR
2024-02-02 Carisma Therapeutics Inc. (CARM) Delisted Grant (A) — $0 EDGAR
2023-08-08 ARTELO BIOSCIENCES, INC. (ARTLW) Delisted Grant (A) — $0 EDGAR
2023-07-03 ARTELO BIOSCIENCES, INC. (ARTLW) Delisted Grant (A) — $0 EDGAR
2023-06-08 Carisma Therapeutics Inc. (CARM) Delisted Grant (A) — $0 EDGAR
Showing 1–10 of 17
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.